
About Ravi Pharmascience Private Limited
Data last updated:
Ravi Pharmascience Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 19 January 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2021PTC353761.
The company has an authorised share capital of ₹10 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vinod Singhania and Siddharth Singhania.
Its last annual general meeting (AGM) was held on 27 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 121 12 Floor Plot – 209 Atlanta Building Jamnalal Bajaj Marg Nariman Point, Mumbai, Maharashtra, India – 400021.
As per the financials filed for FY 2025, the company reported a revenue of ₹1.6 Lakh, a decline of 22% compared to the previous year. For the same year it recorded a net profit of ₹26,240 (net margin 16.4%) and EBITDA of ₹36,049 (EBITDA margin 22.5%). Revenue has declined at a compounded annual rate (CAGR) of 18% over three years.
Its group structure includes 1 subsidiary.
For more details, the company can be reached via its website ravidyeware.com.
Company details
Contact details
Ravi Pharmascience Private Limited's registered office is in Mumbai, Maharashtra. Its website is ravidyeware.com. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Website
- Registered Address121 12 Floor Plot – 209 Atlanta Building Jamnalal Bajaj Marg Nariman Point, Mumbai, Maharashtra, India – 400021
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Ravi Pharmascience Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Ravi Pharmascience is manufacturing. In detail, this covers manufacture of basic pharmaceutical products and pharmaceutical preparations.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | 21 | Manufacture of basic pharmaceutical products and pharmaceutical preparations |
To see the full business activity and turnover split of Ravi Pharmascience Private Limited, buy the company report.
Financials of Ravi Pharmascience Private Limited
FY 2025 filings availableRavi Pharmascience Private Limited reported revenue of ₹1.6 Lakh (down 22% YoY) for FY 2025.
Compounded Annual Growth Rate (CAGR)
Revenue has declined at a compounded annual rate (CAGR) of 18% over three years, including a 22% fall in the latest year. EBITDA fell 75% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹36,049 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹26,240 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 22.5% | ||||
| Net Profit Margin | 16.4% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Ravi Pharmascience Private Limited, buy the company report.
Board of directors of Ravi Pharmascience Private Limited
Ravi Pharmascience has 2 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vinod Singhania Also directs: Unique Dreamscape LLP, Mountview Properties Limited Liability Partnership, Helion Mercantile LLP and 5 more | Director | 19 Jan 2021 | 5 Years 9 Months | Current |
| Siddharth Singhania | Director | 19 Jan 2021 | 5 Years 9 Months | Current |
Auditor
Ravi Pharmascience Private Limited is audited by M.A. Parikh & Co. for the financial year 2023.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| M.A. Parikh & Co. | FY 2023 | 107556W |
Shareholding
The shareholding of Ravi Pharmascience Private Limited is on record for 3 financial years, the latest being FY 2023, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Ravi Pharmascience Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Ravi Pharmascience Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Ravi Pharmascience Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
Group structure & subsidiaries
Ravi Pharmascience has 1 subsidiary company. This group structure data is as of FY 2023. The table lists each entity with its relationship and holding.
| Company Name | CIN | Shares held |
|---|---|---|
| Ravi Biolife Private Limited | U24299MH2020PTC352827 |
To see the full group structure of Ravi Pharmascience Private Limited, buy the company report.
Employees & EPFO
Ravi Pharmascience Private Limited has 1 active EPFO establishment as of Nov 12, 2026.
GST
No GST registration is on our record for Ravi Pharmascience Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Ravi Pharmascience Private Limited has 2 board changes on record since 2021: 2 appointments. The latest: Siddharth Singhania was appointed as Director on 19 Jan 2021.
Frequently asked questions
Ravi Pharmascience is an active private limited company based in Mumbai, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 19 January 2021 (5+ years old) and is registered under CIN U24230MH2021PTC353761.
Ravi Pharmascience has 2 current directors:
- Vinod Singhania - Director
- Siddharth Singhania - Director
The latest financial statements of Ravi Pharmascience on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 27 September 2025. Year-wise statements from FY 2021 are in the company report.
The CIN (Corporate Identification Number) of Ravi Pharmascience is U24230MH2021PTC353761. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Ravi Pharmascience was incorporated on 19 January 2021, making it 5+ years old. It is registered with the Registrar of Companies, Mumbai.
Siddharth Singhania was appointed as Director on 19 Jan 2021. Vinod Singhania was appointed as Director on 19 Jan 2021.
Ravi Pharmascience can be reached through the website ravidyeware.com. Its registered office is in Mumbai, Maharashtra, India.
The registered office of Ravi Pharmascience is at 121 12 Floor Plot – 209 Atlanta Building Jamnalal Bajaj Marg Nariman Point, Mumbai, Maharashtra, India – 400021.
Ravi Pharmascience operates in the pharma industry, in the drug formulation and development segment.
Ravi Pharmascience has 1 subsidiary company including Ravi Biolife Private Limited.

